MedPath

Comparison of clinical significance of novel reactive oxygen species biomarker among new categories of non-ischemic heart failure

Not Applicable
Conditions
non-ischemic heart failure
Registration Number
JPRN-UMIN000035827
Lead Sponsor
Kumamoto University
Brief Summary

DROM measurements can provide important prognostic information for risk stratification in any category of NIHF.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
201
Inclusion Criteria

Not provided

Exclusion Criteria

Do not meet diagnostic criteria for non-ischemic heart failure Severe valvular disease Active infection diseases History of malignancy End stage of chronic kidney diseases

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Composite endpoint of cardiovascular death, non-fatal myocardial infarction, unstable angina pectoris, non-fatal stroke, or re-hospitalization for heart failure
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath